0
0

Stop Pills That Kill Act

12/15/2023, 4:07 PM

Summary of Bill S 1475

Bill 118 s 1475, also known as the Stop Pills That Kill Act, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to address the opioid crisis in the United States by targeting the manufacturers and distributors of prescription painkillers that have been linked to overdose deaths.

The Stop Pills That Kill Act includes several key provisions. First, it would require pharmaceutical companies to pay a fee for every opioid prescription they sell, with the funds raised going towards addiction treatment and prevention programs. This fee is intended to hold drug manufacturers accountable for the role their products have played in the opioid epidemic.

Additionally, the bill would establish stricter regulations for the marketing and distribution of prescription opioids. It would require companies to provide more detailed information about the risks and benefits of these drugs to both healthcare providers and patients. The legislation also includes measures to improve monitoring of opioid prescriptions and to crack down on illegal distribution of these medications. Overall, the Stop Pills That Kill Act aims to address the opioid crisis by targeting the root causes of addiction and overdose deaths. By holding pharmaceutical companies accountable for their role in the epidemic and implementing stricter regulations on the marketing and distribution of prescription opioids, this bill seeks to prevent further harm to individuals and communities affected by opioid addiction.

Congressional Summary of S 1475

Stop Pills That Kill Act

This bill increases criminal penalties for offenses relating to the manufacture of fentanyl or counterfeit substances. It also establishes requirements for federal agencies to address the use of counterfeit substances.

Specifically, the bill applies an increased criminal penalty for possessing, manufacturing, or distributing certain equipment or materials that are used to illegally manufacture fentanyl, an analogue of fentanyl, or a counterfeit substance (the increased penalty is currently limited to offenses involving methamphetamine).

The Drug Enforcement Administration must establish and implement a plan to address counterfeit fentanyl or methamphetamine substances through law enforcement action and education and prevention efforts. In addition, the Department of Justice must annually report on the collection of counterfeit fentanyl or methamphetamine substances by law enforcement and on related prosecutions.

Current Status of Bill S 1475

Bill S 1475 is currently in the status of Bill Introduced since May 9, 2023. Bill S 1475 was introduced during Congress 118 and was introduced to the Senate on May 9, 2023.  Bill S 1475's most recent activity was Read twice and referred to the Committee on the Judiciary. as of May 9, 2023

Bipartisan Support of Bill S 1475

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
0
Democrat Cosponsors
0
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 1475

Primary Policy Focus

Crime and Law Enforcement

Comments

Latest Bills

To authorize the Secretary of Education, in collaboration with the Secretary of Health and Human Services, to establish an interagency advisory Commission on Advancing Restorative Justice in Elementary and Secondary Education, and for other purposes.
Bill HR 8360April 17, 2026
To amend the Higher Education Act of 1965 to remove all adverse credit history related to a loan from the credit history of a borrower who has rehabilitated the loan.
Bill HR 8361April 17, 2026
To reauthorize the YouthBuild program, and for other purposes.
Bill HR 8333April 17, 2026
To raise the Foreign Service mandatory retirement age by aligning it with the Social Security Full Retirement Age, and for other purposes.
Bill HR 8346April 17, 2026
To amend the FISA Amendments Act of 2008 to extend the authorities of title VII of the Foreign Intelligence Surveillance Act of 1978 through April 30, 2026, and for other purposes.
Bill HR 8322April 17, 2026
To amend title II of the Social Security Act to repeal the retirement earnings test, and for other purposes.
Bill HR 8344April 17, 2026
To amend section 133 of title 23, United States Code, to remove a certain State funding set-aside for transportation alternative programs, and for other purposes.
Bill HR 8349April 17, 2026
To amend title XI of the Social Security Act to require the Center for Medicare and Medicaid Innovation to test a model to reduce chronic diseases by using accountable produce is medicine.
Bill HR 8355April 17, 2026
To amend the Federal Food, Drug, and Cosmetic Act to enhance drug manufacturing amount information reporting, and for other purposes.
Bill HR 8339April 17, 2026
Supporting the designation of the week of April 11 through April 17, 2026, as "Black Maternal Health Week", founded by Black Mamas Matter Alliance, Inc. (BMMA), to bring national attention to the maternal and reproductive health crisis in the United States and the importance of reducing maternal mortality and morbidity among Black women and birthing people.
Bill HRES 1183April 17, 2026